Author:
Menanteau Melissa Rieger,Martinez-Climent Jose A.
Reference113 articles.
1. Swerlow SH, Berger F, Isaacson P, Muller-Hermelink HK, Nathwani BN, Piris MA, Harris NL (2001) Mantle cell lymphoma. World Health Organization Classification of tumors pathology and genetics of tumours of haematopoietic and lymphoid tissues:168–170
2. Orchard J, Garand R, Davis Z et al (2003) A subset of t(11;14) lymphoma with mantle cell features displays mutated igvh genes and includes patients with good prognosis, nonnodal disease. Blood 101(12):4975–4981. doi:10.1182/blood-2002-06-1864 2002-06-1864 [pii]
3. Rubio-Moscardo F, Climent J, Siebert R et al (2005) Mantle-cell lymphoma genotypes identified with cgh to bac microarrays define a leukemic subgroup of disease and predict patient outcome. Blood 105(11):4445–4454. doi:2004-10-3907 [pii] 10.1182/blood-2004-10-3907
4. Fernandez V, Salamero O, Espinet B et al (2010) Genomic and gene expression profiling defines indolent forms of mantle cell lymphoma. Cancer Res 70(4):1408–1418. doi:0008-5472.CAN-09-3419 [pii] 10.1158/0008-5472.CAN-09-3419
5. Dreyling M, Hiddemann W (2008) Dose-intense treatment of mantle cell lymphoma: can durable remission be achieved? Curr Opin Oncol 20(5):487–494. doi:10.1097/CCO.0b013e32830b61c2 00001622-200809000-00002 [pii]
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献